Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis.

Microvascular endothelial cells (RFCs) cultured in two-dimensional (2D) cultures proliferate rapidly and exhibit an undifferentiated phenotype. Addition of transforming growth factor beta1 (TGFbeta1) increases fibronectin expression and inhibits proliferation. RFCs cultured in three-dimensional (3D) type I collagen gels proliferate slowly and are refractory to the anti-proliferative effects of TGF beta1. TGF beta1 promotes tube formation in 3D cultures. TGF beta1 increases fibronectin expression and urokinase plasminogen activator (uPA) activity and plasminogen activator inhibitor-1 (PAI-1) levels in 3D cultures. Since the TGF beta type I and II receptors have been reported to regulate different activities induced by TGF beta1, we compared the TGF beta receptor profiles on cells in 2D and 3D cultures. RFCs in 3D cultures exhibited a significant loss of cell surface type II receptor compared with cells in 2D cultures. The inhibitory effect of TGF beta1 on proliferation is suppressed in transfected 2D cultures expressing a truncated form of the type II receptor, while its stimulatory effect on fibronectin production is reduced in both 2D and 3D transfected cultures expressing a truncated form of the type I receptor. These data suggest that the type II receptor mediates the antiproliferative effect of TGF beta1 while the type I receptor mediates the matrix response of RFCs to TGF beta1 and demonstrate that changes in the matrix environment can modulate the surface expression of TGF beta receptors, altering the responsiveness of RFCs to TGF beta1.

[1]  M. Centrella,et al.  Expression of Transforming Growth Factor Type III Receptor in Vascular Endothelial Cells Increases Their Responsiveness to Transforming Growth Factor β2 (*) , 1995, The Journal of Biological Chemistry.

[2]  V. Rosen,et al.  Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype , 1995, Molecular and cellular biology.

[3]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[4]  E. Sage,et al.  PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors , 1994, The Journal of cell biology.

[5]  S. Friedman,et al.  Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. , 1994, The Journal of biological chemistry.

[6]  A. M. Romanic,et al.  Extracellular Matrix‐Degrading Proteinases in the Nervous System , 1994, Brain pathology.

[7]  K. Miyazono,et al.  Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. , 1993, Experimental cell research.

[8]  R. Derynck,et al.  Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. , 1993, Science.

[9]  J. Gamble,et al.  Regulation of in vitro capillary tube formation by anti-integrin antibodies , 1993, The Journal of cell biology.

[10]  A. Ullrich,et al.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.

[11]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[12]  M. Centrella,et al.  Multiple regulatory effects by transforming growth factor-beta on type I collagen levels in osteoblast-enriched cultures from fetal rat bone. , 1992, Endocrinology.

[13]  R. Derynck,et al.  Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1 , 1992, The Journal of cell biology.

[14]  J. Madri,et al.  Modulation of vascular cell behavior by transforming growth factors β , 1992, Molecular reproduction and development.

[15]  J. Madri,et al.  Matrix composition, organization and soluble factors: modulators of microvascular cell differentiation in vitro. , 1992, Kidney international.

[16]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[17]  M. Sporn,et al.  Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. , 1992, The Journal of biological chemistry.

[18]  D. Belin,et al.  The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.

[19]  E. Canalis,et al.  Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone , 1991, Molecular and cellular biology.

[20]  C. Prinz,et al.  Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: Models of de‐endothelialization and repair , 1991, Journal of cellular biochemistry.

[21]  R. Montesano,et al.  Proteolytic balance and capillary morphogenesis. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[22]  J. Massagué,et al.  Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. , 1990, The Journal of biological chemistry.

[23]  J. Massagué,et al.  Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. , 1990, The Journal of biological chemistry.

[24]  H. Moses,et al.  Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane , 1990, The Journal of cell biology.

[25]  L. Orci,et al.  Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro , 1990, The Journal of cell biology.

[26]  E. Olson,et al.  Functional receptors for transforming growth factor-beta are retained by biochemically differentiated C2 myocytes in growth factor-deficient medium containing EGTA but down-regulated during terminal differentiation. , 1990, The Journal of biological chemistry.

[27]  O. Kocher,et al.  Transforming growth factor beta1 modulates extracellular matrix organization and cell‐cell junctional complex formation during in vitro angiogenesis , 1990, Journal of cellular physiology.

[28]  Donald E. Ingber,et al.  How does extracellular matrix control capillary morphogenesis? , 1989, Cell.

[29]  H. Kleinman,et al.  Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro , 1989, Cell.

[30]  P. Segarini,et al.  Binding of transforming growth factor-beta to cell surface proteins varies with cell type. , 1989, Molecular endocrinology.

[31]  J. Wrana,et al.  Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. , 1989, The Journal of biological chemistry.

[32]  E. Canalis,et al.  Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Chambaz,et al.  Bovine adrenocortical cells exhibit high affinity transforming growth factor-beta receptors which are regulated by adrenocorticotropin. , 1988, The Journal of biological chemistry.

[34]  J. Madri,et al.  Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix , 1988, The Journal of cell biology.

[35]  G. Spizz,et al.  Decrease in transforming growth factor-beta binding and action during differentiation in muscle cells. , 1988, The Journal of biological chemistry.

[36]  M. Laiho,et al.  Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. , 1987, The Journal of biological chemistry.

[37]  D. Moscatelli,et al.  The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells , 1987, The Journal of cell biology.

[38]  W. Birchmeier,et al.  Inhibitory action of transforming growth factor beta on endothelial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Nicosia,et al.  The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. , 1987, The American journal of pathology.

[40]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[41]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[42]  L. Orci,et al.  Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Jimenez,et al.  Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-beta. , 1986, Biochemical and biophysical research communications.

[44]  L. Matrisian,et al.  Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts , 1986, Molecular and cellular biology.

[45]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[46]  M. Klagsbrun,et al.  Purification and characterization of heparin-binding endothelial cell growth factors. , 1986, The Journal of biological chemistry.

[47]  L. Orci,et al.  Tumor-promoting phorbol esters induce angiogenesis in vitro , 1985, Cell.

[48]  Stuart K Williams,et al.  Capillary endothelial cell cultures: phenotypic modulation by matrix components , 1983, The Journal of cell biology.

[49]  H. Furthmayr,et al.  Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis. , 1980, Human pathology.

[50]  F. Roll,et al.  Codistribution of collagen types IV and AB2 in basement membranes and mesangium of the kidney. an immunoferritin study of ultrathin frozen sections , 1980, The Journal of cell biology.

[51]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[52]  R. Perlmutter,et al.  Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. , 1994, The Journal of clinical investigation.

[53]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[54]  K. Miyazono,et al.  Receptors for transforming growth factor-beta. , 1994, Advances in immunology.

[55]  H. Lodish,et al.  Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases. , 1993, Trends in cell biology.

[56]  F. Blasi Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[57]  W. Newman,et al.  Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro. , 1991, The American journal of pathology.

[58]  P. Bohlen,et al.  Basic FGF Treatment of Endothelial Cells Down-regulates the 85-KDa TGFβ Receptor Subtype and Decreases the Growth Inhibitory Response to TGF-β1 , 1990 .

[59]  James F. Battey,et al.  Peptide growth factors and their receptors , 1990 .

[60]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.